Why CorePharma?

Bringing a pharmaceutical product from early concept to full-scale commercialization requires technical depth, operational discipline, and a partner that understands regulatory and manufacturing realities. This overview highlights a fully integrated CDMO platform designed to support development and manufacturing across the product lifecycle, with capabilities rooted in U.S.-based, cGMP-compliant facilities.

A broad range of solid oral dose and liquid manufacturing services are supported by formulation development, analytical testing, stability programs, and regulatory expertise — creating a streamlined path from clinical supply to commercial production. Advanced processing capabilities, scalable equipment, and high annual unit capacity enable flexibility for both emerging and established programs, while short lead times and supply chain optimization help teams stay on track.

Quality systems, FDA- and DEA-approved sites, and experienced technical teams form the backbone of an approach that prioritizes reliability, compliance, and partnership. For organizations seeking an efficient, end-to-end manufacturing strategy without sacrificing quality or control, this resource offers a clear view into what a concept-to-commercial model can deliver. Explore the full brochure to see how these capabilities align with your development goals.